Get the latest Science News and Discoveries

Treatment options for hepatocellular carcinoma using immunotherapy: present and future - EurekAlert


Hepatocellular carcinoma (HCC) is a primary liver cancer predominantly arising from chronic liver diseases such as hepatitis B and C infections, alcohol abuse, and metabolic disorders. It's one of the most common cancers worldwide and is increasingly prevalent in Western countries. Effective treatment options for HCC vary depending on tumor load, location, and comorbidities, including liver transplantation, surgical resection, percutaneous ablation, trans-arterial chemoembolization (TACE), and radio-embolization.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of Treatment options

Treatment options

Photo of Immunotherapy

Immunotherapy

Related news:

News photo

Treatment with a mixture of antimicrobial peptides can impede antibiotic resistance - EurekAlert

News photo

Regulation needed to curb favoritism between countries and credit rating agencies, new research suggests - EurekAlert

News photo

A new breakthrough in understanding regeneration in a marine worm - EurekAlert